Nutrition and the brain: What advice should we give?

Neurobiology of Aging

Volumn 35, Issue SUPPL.2, 2014, Pages

  Cooper, James K ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Brain; Dementia; Nutrition; Regulatory agencies

Indexed keywords

OMEGA 3 FATTY ACID;

ALZHEIMER DISEASE; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; DISEASE CONTROL; EXPECTATION; FOOD SAFETY; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; NUTRIENT MANAGEMENT; NUTRITION; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; PERSUASIVE COMMUNICATION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK REDUCTION; AGE; AGING; BRAIN PROTECTION; DISEASE SEVERITY; HEALTH CARE NEED; INTERNATIONAL COOPERATION; NEUROPROTECTION; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TREATMENT OUTCOME; BRAIN; BRAIN DAMAGE, CHRONIC; DEMENTIA; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; PHYSIOLOGY; RESEARCH;

AGING; ALZHEIMER DISEASE; BRAIN; BRAIN DAMAGE, CHRONIC; DEMENTIA; HEALTH SYSTEMS AGENCIES; HUMANS; NUTRITION POLICY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RESEARCH;

EID: 84903744113     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.029     Document Type: Review

References (39)

1. Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services. 2013. National Plan to Address Alzheimer's Disease: 2013 Update. Available at:. Accessed June 1, 2014. http://www.aspe.hhs.gov/daltcp/napa/NatlPlan2013.pdf.
2. Barnard, N.D., 2014. Guidelines for the Prevention of Alzheimer's Disease. Neurobiol. Aging (this issue).
3. Bertonie A.G., Whitt-Glover M.C. DASH for cash?. JAMA Intern. Med. 2013, 173:1924-1925.
4. Bowman G.L., Silbert L.C., Howieson D., Dodge H.H., Traber M.G., Frei B., Quinn J.F. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78:241-249.
5. Brasky T.M., Darke A.K., Song X., Tangen C.M., Goodman P.J., Thompson I.M., Kristal A.R. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J.Natl. Cancer Inst. 2013, 105:1132-1141.
6. Carbone I., Lazzarotto T., Ianni M., Porcellini E., Forti P., Masliah E., Licastro F. Herpes virus in Alzheimer's disease: relation to progression of the disease. Neurobiol. Aging 2013, 35:122-129.
7. Centers for Disease Control and Prevention (CDC). 2013. Most Americans Consume Too Much Sodium. Available at:. Accessed June 1, 2014. http://www.cdc.gov/bloodpressure/sodium.htm.
8. Craft S., Cholerton B., Baker L.D. Insulin and Alzheimer's disease: untangling the web. J.Alzheimers Dis. 2013, 33:S263-S275.
9. DaVanzo J.E., Heath S., El-Gamil, A., Dobson, A., 2009. The Economic Contribution ofthe Dietary Supplement Industry-Analyses of the Economic Benefits to theU.S. Economy. Available at:. http://www.naturalproductsfoundation.org/clientuploads/NPF%20-%20Economic%20Impact%20Study.pdf.
10. Daviglus M.L., Bell C.C., Berrettini W., Bowen P.E., Connolly E.S., Cox N.J., Trevisan M. National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer's disease and cognitive decline. Ann. Intern. Med. 2010, 153:176-181.
11. Dugger B.N., Hidalgo J.A., Chiarolanza G., Mariner M., Henry-Watson J., Sue L.I., Beach T.G. The distribution of phosphorylated tau in spinal cords of Alzheimer's disease and non-demented individuals. J.Alzheimers Dis. 2013, 34:529-536.
12. Federal Trade Commission (FTC), 2013. Dietary Supplements. Available at:. Accessed August 16,2013. http://www.consumer.ftc.gov/articles/0261-dietary-supplements.
13. Food and Drug Administration (FDA). 2013. Claims That Can Be Made for Conventional Foods and Dietary Supplements. Available at:. Accessed September 20,2013. http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm111447.htm.
14. Food and Nutrition Board, Institute of Medicine, National Academies, 2010. DietaryReference Intakes (DRIs). Estimated Average Requirements. Available at:. Accessed 16 August2013. mailto:http://www.iom.edu/Activities/Nutrition/SummaryDRIs/%7E/media/Files/Activity%20Files/Nutrition/DRIs/5_Summary%20Table%20Tables%201-4.pdf.
15. Gahche J., Bailey R., Burt, V., Hughes, J., Yetley, E., Dwyer, J., Picciano, M.F., McDowell, M., Sempos, C., 2011. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief No. 61. Available at:. Accessed August 16,2013. http://www.cdc.gov/nchs/data/databriefs/db61.htm.
16. Galasko D.R., Peskind E., Clark C.M., Quinn J.F., Ringman J.M., Jicha G.A., Aisen P. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 2012, 69:836-841.
17. Gartlehner G., Hansen R.A., Nissman D, Lohr, K.N., Carey, T.S., 2006. Criteria for distinguishing effectiveness from efficacy trials in systematic reviews. Technical Review, No. 12. Available at:. Accessed August 16,2013. http://www.ncbi.nlm.nih.gov/books/NBK44024/.
18. Government Printing Office, 2010. Food and Drugs. Chapter 9: Federal Food, Drug, and Cosmetic Act. Subchapter II: Definitions (21 U.S.C. (ff)). United States Code. Available at:. Accessed August 16,2013. http://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/html/USCODE-2010-title21-chap9-subchapII.htm.
19. Griffin W.S. Neuroinflammatory cytokine signaling and Alzheimer's disease. N.Engl. J. Med. 2013, 368:770-771.
20. Hartmann T. Intracellular biology of Alzheimer's disease amyloid beta peptide. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249:291-298.
21. Hurd M.D., Martorell P., Langa K.M. Monetary costs of dementia in the United States. N.Engl. J. Med. 2013, 369:489-490.
22. Institute of Medicine, 2013. National Academy of Sciences. Sodium Intake in Populations: Assessment of Evidence. Available at:. http://www.nap.edu/openbook.php?record_id=18311.
23. Jack C.R., Albert M.S., Knopman D.S., McKhann G.M., Sperling R.A., Carrillo M.C., Phelps C.H. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:257-262.
24. Keefe R.S., Kraemer H.C., Epstein R.S., Frank E., Haynes G., Laughren T.P., Leon A.C. Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials. Innov. Clin. Neurosci. 2013, 10:4S-19S.
25. Lo R.Y., Jagust W.J. Vascular burden and Alzheimer disease pathologic progression. Neurology 2012, 79:1349-1355.
26. Matthews F.E., Arthur A., Barnes L.E., Bond J., Jagger C., Robinson L., Brayne C. Atwo-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013.
27. Mozaffarian D., Lemaitre R.N., King I.B., Song X., Huang H., Sacks F.M., Siscovick D.S. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann. Intern. Med. 2013, 158:515-525.
28. National Agricultural Library, 1998. Joint Collection Development Policy: Human Nutrition and Food. Available at:. Accessed August 16,2013. http://www.nlm.nih.gov/pubs/cd_hum.nut.html.
29. National Institute of Neurological Disorders and Stroke, 2013. Alzheimer's Disease-Related Dementias: Research Challenges and Opportunities. Available at:. Accessed August 16,2013. http://videocast.nih.gov/summary.asp?live=12655.
30. National Institute on Aging, 2013a. Search for Clinical Trials. Available at:. mailto:http://www.nia.nih.gov/alzheimers/clinical-trials/results.
31. National Institute on Aging, 2013b. Alzheimer's Disease Research Summit Offers Research Recommendations May 15, 2013. Available at:. Accessed August 16,2013. mailto:http://www.nia.nih.gov/newsroom/announcements/2012/05/alzheimers-disease-research-summit-offers-research-recommendations.
32. National Institute on Aging, 2013c. Plans for Healthy Eating. Available at:. mailto:http://www.nia.nih.gov/health/publication/whats-your-plate/plans-healthy-eating.
33. Nicastro H.L., Dunn B.K. Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT). Nutrients 2013, 5:1122-1148.
34. Pearce M.L., Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet 1971, 1:464-467.
35. Rocca W.A., Petersen R.C., Knopman D.S., Hebert L.E., Evans D.A., Hall K.S., White L.R. Trends in the incidence and prevalence of Alzheimer's disease, dementia, andcognitive impairment in the United States. Alzheimer's Dement. 2011, 7:80-93.
36. Roncaglioni M.C., Tombesi M., Avanzini F., Barlera S., Caimi V., Longoni P., Marchioli R. n-3 fatty acids in patients with multiple cardiovascular risk factors. N.Engl. J. Med. 2013, 368:1800-1808.
37. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Thal L.J. Acontrolled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N.Engl. J. Med. 1997, 336:1216-1222.
38. Wildsmith K.R., Holley M., Savage J.C., Skerrett R., Landreth G.E. Evidence for impaired amyloid beta clearance in Alzheimer's disease. Alzheimers Res. Ther. 2013, 5:33.
39. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.